After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Axogen Inc. (AXGN) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.04, or -0.71%, to $5.58. The Axogen Inc. has recorded 1,142,218 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Axogen, Inc. Reports 2023 Third Quarter Financial Results.
AXGN belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $5.62 and fluctuated between $5.83 as its day high and $5.41 as its day low. The current market capitalization of Axogen Inc. is $241.88M. A total of 1.34 million shares were traded on the day, compared to an average of 383.02K shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, AXGN has seen 4 BUY and 0 SELL insider trades, representing the acquisition of 36,000 and the disposition of 0 shares. Over the last 12 months, there were 45 BUYs and 34 SELLs from insiders. Insiders purchased 420,880 shares during that period but sold 211,018.
In the most recent transaction, Wendell Amy McBride bought 10,000 shares of AXGN for 6.22 per share on Sep 06. After the transaction, the Director now owns 80,342 company shares. In a previous transaction on Aug 23, Burke William P. Mr. bought 10,000 shares at 6.56 per share. AXGN shares that Director owns now total 10,000.
Among the insiders who bought shares, NEELS GUIDO J acquired of 10,000 shares on Aug 16 at a per-share price of $6.11. This resulted in the Director holding 68,259 shares of AXGN after the transaction. In another insider transaction, Freitag Gregory Gene sold 41,980 shares at $8.71 per share on Jun 01. Company shares held by the Director now total 290,135.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for AXGN in the last 3 months, the mean price target is $11.50 with high estimates of $17.00 and low estimates of $9.00. In terms of 52-week highs and lows, AXGN has a high of $13.07 and a low of $3.45.
As of this writing, AXGN has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.17. The company reported an EPS of -$0.03 in the last quarter, which was 76.90% higher than expectations of -$0.13.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AXGN’s latest balance sheet shows that the firm has $84.09M in Cash & Short Term Investments as of fiscal 2021. There were $67.45M in debt and $24.29M in liabilities at the time. Its Book Value Per Share was $2.27, while its Total Shareholder’s Equity was $112.55M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AXGN is Buy with a score of 5.00.